-transparent.png){kind=logo}
Methotrexate therapy has been effective in the treatment of RA with short term experience suggesting little serious adverse reactions. Our review of 168 patients receiving methotrexate has identified nine patients with probable or possible methotrexate-induced pulmonary toxicity, giving a prevalence of 5% and an incidence of 3.9 per 100 patients per year. No clinical or laboratory features showed an association that could potentially predict the development of pulmonary disease. All patients experienced complete recovery with supportive care and/or corticosteroid therapy. Clinical monitoring for this complication is warranted in all patients receiving long term methotrexate therapy for RA.
C W Carson, and
G W Cannon, and
M J Egger, and
J R Ward, and
D O Clegg
January 1980,
The Journal of rheumatology,
C W Carson, and
G W Cannon, and
M J Egger, and
J R Ward, and
D O Clegg
December 2001,
Ryumachi. [Rheumatism],
C W Carson, and
G W Cannon, and
M J Egger, and
J R Ward, and
D O Clegg
November 1985,
Seminars in arthritis and rheumatism,
C W Carson, and
G W Cannon, and
M J Egger, and
J R Ward, and
D O Clegg
June 1995,
Seminars in arthritis and rheumatism,
C W Carson, and
G W Cannon, and
M J Egger, and
J R Ward, and
D O Clegg
February 1992,
Ryumachi. [Rheumatism],
C W Carson, and
G W Cannon, and
M J Egger, and
J R Ward, and
D O Clegg
March 1996,
Clinical pharmacokinetics,
C W Carson, and
G W Cannon, and
M J Egger, and
J R Ward, and
D O Clegg
October 1983,
Arthritis and rheumatism,
C W Carson, and
G W Cannon, and
M J Egger, and
J R Ward, and
D O Clegg
May 1994,
Revue du rhumatisme (Ed. francaise : 1993),
C W Carson, and
G W Cannon, and
M J Egger, and
J R Ward, and
D O Clegg
August 1990,
Annals of the rheumatic diseases,
C W Carson, and
G W Cannon, and
M J Egger, and
J R Ward, and
D O Clegg
January 1982,
The Journal of rheumatology,
